FindTrial
Sign In

Effect of pumpkin seed oil versus tamsulosin on relieving clinical symptom in patients with benign prostatic hypertrophy

Effect of pumpkin seed oil versus tamsulosin on relieving clinical symptom in patients with benign prostatic hypertrophy: a single blinded randomized controlled trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201611019014N128
Enrollment
80
Registered
2016-11-09
Start date
2015-04-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

benign prostatic hypertrophy. Hyperplasia of prostate

Interventions

Intervention 1: Intervention group: Pumpkin seed oil 20 drop twice a day for 3 months. Intervention 2: Control group: Tamsulosin casual 0.4 mg per day for 3 months.
Treatment - Drugs
Intervention group: Pumpkin seed oil 20 drop twice a day for 3 months.
Control group: Tamsulosin casual 0.4 mg per day for 3 months

Sponsors

Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Benign prostatic hypertrophy; age of 50 to 80 years. Exclusion criteria: Indication of surgery; no response to medical treatment.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Clinical symptoms. Timepoint: before, and 1, 2, and 3 months after intervention. Method of measurement: through history taking.;Maximum urine flow rate. Timepoint: before and 3 months after intervention. Method of measurement: using uroflowmetry.—

Secondary

MeasureTime frame
Quality of life. Timepoint: before and 3 months after intervention. Method of measurement: using standard quality of life questionnaire.—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Mahmood Ebrahimi

Shahid Beheshti Hospital

drmebrahimi22@yahoo.com+98 81 3838 0283

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026